This paper was commissioned for the aids2031 Science and Technology Working Group as part of a series of working papers under the aids2031 initiative. This paper explores issues that could be included in a future research agenda to enhance drug development for HIV/AIDS, including the optimal time to begin antiretroviral therapy, appropriate dosing of antiretrovirals, possible implications of HIV on advanced aging, and an exploration of recent challenges in drug development.

Author(s): Becker S

Corporate author(s): aids2031 Science and Technology Working Group

Publication date: November 2008

Available materials


Emerging Trends in HIV Pathogenesis and Treatment

179 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

This publication is part of the series aids2031 working papers

Related regions: Global

See also: Emerging and epidemic diseases > HIV and AIDS

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA